Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1971 1
1974 2
1976 1
1977 1
1978 2
1979 1
1980 4
1981 1
1983 1
1984 1
1985 1
1986 2
1990 1
1991 1
1992 1
1993 1
1996 1
1997 2
1998 5
1999 3
2000 1
2001 1
2002 2
2003 3
2004 4
2005 6
2006 5
2007 6
2008 5
2009 5
2010 7
2011 7
2012 8
2013 11
2014 10
2015 25
2016 21
2017 13
2018 11
2019 7
2020 4
Text availability
Article attribute
Article type
Publication date

Search Results

182 results
Results by year
Filters applied: . Clear all
Page 1
Showing results for Tamas tumor
Your search for Tamás Tomor retrieved no results
Rectal and colon cancer: Not just a different anatomic site.
Tamas K, Walenkamp AM, de Vries EG, van Vugt MA, Beets-Tan RG, van Etten B, de Groot DJ, Hospers GA. Tamas K, et al. Cancer Treat Rev. 2015 Sep;41(8):671-9. doi: 10.1016/j.ctrv.2015.06.007. Epub 2015 Jun 28. Cancer Treat Rev. 2015. PMID: 26145760 Review.
Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study.
André T, de Gramont A, Vernerey D, Chibaudel B, Bonnetain F, Tijeras-Raballand A, Scriva A, Hickish T, Tabernero J, Van Laethem JL, Banzi M, Maartense E, Shmueli E, Carlsson GU, Scheithauer W, Papamichael D, Möehler M, Landolfi S, Demetter P, Colote S, Tournigand C, Louvet C, Duval A, Fléjou JF, de Gramont A. André T, et al. J Clin Oncol. 2015 Dec 10;33(35):4176-87. doi: 10.1200/JCO.2015.63.4238. Epub 2015 Nov 2. J Clin Oncol. 2015. PMID: 26527776 Clinical Trial.
Ninety-five patients (9.4%) had MMR-deficient (dMMR) tumors, and 94 (10.4%) had BRAF mutation. BRAF mutation was not prognostic for OS (P = .965), but dMMR was an independent prognostic factor (HR, 2.02; 95% CI, 1.15 to 3.55; P = .014). ...
Ninety-five patients (9.4%) had MMR-deficient (dMMR) tumors, and 94 (10.4%) had BRAF mutation. BRAF mutation was not prognostic for O …
A Tumor Mitochondria Vaccine Protects against Experimental Renal Cell Carcinoma.
Pierini S, Fang C, Rafail S, Facciponte JG, Huang J, De Sanctis F, Morgan MA, Uribe-Herranz M, Tanyi JL, Facciabene A. Pierini S, et al. J Immunol. 2015 Oct 15;195(8):4020-7. doi: 10.4049/jimmunol.1500281. Epub 2015 Sep 16. J Immunol. 2015. PMID: 26378078 Free article.
The resulting altered mitochondrial proteins or tumor-associated mitochondrial Ags (TAMAs) are potentially immunogenic, suggesting that they may be targetable Ags for cancer immunotherapy. In this article, we show that the RENCA tumor cell line harbors TAM
The resulting altered mitochondrial proteins or tumor-associated mitochondrial Ags (TAMAs) are potentially immunogenic, sugges …
Cannabinoid Signaling in the Skin: Therapeutic Potential of the "C(ut)annabinoid" System.
Tóth KF, Ádám D, Bíró T, Oláh A. Tóth KF, et al. Molecules. 2019 Mar 6;24(5):918. doi: 10.3390/molecules24050918. Molecules. 2019. PMID: 30845666 Free PMC article. Review.
., atopic dermatitis, psoriasis, scleroderma, acne, hair growth and pigmentation disorders, keratin diseases, various tumors, and itch. ...
., atopic dermatitis, psoriasis, scleroderma, acne, hair growth and pigmentation disorders, keratin diseases, various tumors, and itc …
Mixed Ovarian Tumor Composed of Brenner Tumor and Adult-Type Granulosa Cell Tumor: A Case Report of a Very Rare Mixed Ovarian Tumor and a Review of the Literature.
Tamás J, Vereczkey I, Tóth E, Csernák E, Purcsi K, Pete I. Tamás J, et al. Int J Surg Pathol. 2018 Jun;26(4):382-387. doi: 10.1177/1066896917744877. Epub 2017 Dec 3. Int J Surg Pathol. 2018. PMID: 29198156 Review.
A combination of ovarian tumors with the same histogenetic origin but different histologic subtype is relatively common, whereas a co-occurrence of tumors with different histogenetic origin is rare. We report a case of mixed ovarian tumor composed of Brenner …
A combination of ovarian tumors with the same histogenetic origin but different histologic subtype is relatively common, whereas a co …
Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results of the Pivotal Phase II BELIEF (CLN-19) Study.
O'Connor OA, Horwitz S, Masszi T, Van Hoof A, Brown P, Doorduijn J, Hess G, Jurczak W, Knoblauch P, Chawla S, Bhat G, Choi MR, Walewski J, Savage K, Foss F, Allen LF, Shustov A. O'Connor OA, et al. J Clin Oncol. 2015 Aug 10;33(23):2492-9. doi: 10.1200/JCO.2014.59.2782. Epub 2015 Jun 22. J Clin Oncol. 2015. PMID: 26101246 Free PMC article. Clinical Trial.
The integration of inflammaging in age-related diseases.
Fulop T, Witkowski JM, Olivieri F, Larbi A. Fulop T, et al. Semin Immunol. 2018 Dec;40:17-35. doi: 10.1016/j.smim.2018.09.003. Epub 2018 Oct 2. Semin Immunol. 2018. PMID: 30287177 Review.
Health-Related Quality-of-Life Results From the Open-Label, Randomized, Phase III ASPIRE Trial Evaluating Carfilzomib, Lenalidomide, and Dexamethasone Versus Lenalidomide and Dexamethasone in Patients With Relapsed Multiple Myeloma.
Stewart AK, Dimopoulos MA, Masszi T, Špička I, Oriol A, Hájek R, Rosiñol L, Siegel DS, Niesvizky R, Jakubowiak AJ, San-Miguel JF, Ludwig H, Buchanan J, Cocks K, Yang X, Xing B, Zojwalla N, Tonda M, Moreau P, Palumbo A. Stewart AK, et al. J Clin Oncol. 2016 Nov 10;34(32):3921-3930. doi: 10.1200/JCO.2016.66.9648. J Clin Oncol. 2016. PMID: 27601539 Free PMC article. Clinical Trial.
Expression of PD-L1 on Immune Cells Shows Better Prognosis in Laryngeal, Oropharygeal, and Hypopharyngeal Cancer.
Birtalan E, Danos K, Gurbi B, Brauswetter D, Halasz J, Kalocsane Piurko V, Acs B, Antal B, Mihalyi R, Pato A, Fent Z, Polony G, Timar J, Tamas L. Birtalan E, et al. Appl Immunohistochem Mol Morphol. 2018 Aug;26(7):e79-e85. doi: 10.1097/PAI.0000000000000590. Appl Immunohistochem Mol Morphol. 2018. PMID: 29271789
Proportion of tumor-infiltrating lymphocytes was assessed as well. In HPV-negative tumors, PD-L1 immune cell positivity was associated with better disease-specific survival. PD-L1 expression on immune cells correlated with improved disease-specific survival in laryn …
Proportion of tumor-infiltrating lymphocytes was assessed as well. In HPV-negative tumors, PD-L1 immune cell positivity was as …
Szerkesztőségi köszöntő.
Tamás T, Sándor F. Tamás T, et al. Psychiatr Hung. 2016;31(2):105. Psychiatr Hung. 2016. PMID: 27487583 Hungarian. No abstract available.
182 results
Jump to page
Feedback